In addition, it was found that the phagocytosis of TAM was enhanced by immune checkpoint inhibitors such as PD-1/PD-L1 inhibitors, CD47 inhibitor (Hu5F9-G4), CD40 antibody (selicrelumab), and trastuzumab, reduced tumor burden (12–15). The gene discussed is CD274; the disease is neoplasm.